Clinical trial · Interventional
Study of Anxiety After a Session of Energy Resonance by Cutaneous Stimulation
Study of the Reduction of Anxiety After a Session of Energy Resonance by Cutaneous Stimulation in the Management of Patients Requiring Breast Macrobiopsy.
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Performing a breast macrobiopsy can be extremely delicate and anxiety-provoking. It can have an impact on the course of future examinations. Patients' emotional feelings also have a definite impact on the nursing staff. The purpose of the MBRESC study is to evaluate Energy Resonance by Cutaneous Stimulation , a manual acupressure technique, in the management of anxiety prior to breast macrobiopsy.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Neoplasm | Breast Neoplasm | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Energy Resonance by Cutaneous Stimulation | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Energy Resonance by Cutaneous Stimulation
- description
- one Energy Resonance by Cutaneous Stimulation session performed before macrobiopsy
- interventionNames
- Other: Energy Resonance by Cutaneous Stimulation
Primary outcomes (1)
- measure
- Evaluation of the reduction in ANXIETY STATE
- timeFrame
- 1 day
- description
- Evaluation of anxiety before and after RESC session using Spielberger scale
Secondary outcomes (2)
- measure
- Evaluation of the reduction in ANXIETY STATE
- timeFrame
- 3 days
- description
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patient has received full information on the organization and purpose of the research, and has signed an informed consent form. * Patient over 18 years of age * Patient undergoing a diagnostic breast macrobiopsy for suspected breast cancer * Patient undergoing a macro breast biopsy for the first time * Patient affiliated to or benefiting from a social security schem Exclusion Criteria: * Patient with a history of breast cancer or other pathologies requiring invasive procedures * Patient with several lesions to be biopsied * Patient with psychiatric pathology * Patient under anxiolytic or psychotropic treatment initiated in the month before the breast macrobiopsy
References
Publications (0)
Data not yet available